Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma
These findings underscore the importance of monitoring and managing treatment-related AEs and maintaining the HRQoL. They also highlight the crucial and reassuring role of multidisciplinary care in enhancing treatment outcomes in this cohort.
Authors
- Masako Shomura (ORCID: https://orcid.org/0000-0002-2721-9921)
- Mamoru Sakakibara (ORCID: https://orcid.org/0000-0002-8278-7542)
- Yusuke Mishima
- Yoshitaka Arase (ORCID: https://orcid.org/0000-0001-8498-3128)
- Kota Tsuruya (ORCID: https://orcid.org/0000-0002-9884-8039)
- Haruka Okabe (ORCID: https://orcid.org/0000-0002-9270-7243)
- Tatehiro Kagawa (ORCID: https://orcid.org/0000-0002-3442-1423)
- Shunji Hirose (ORCID: https://orcid.org/0000-0001-6116-340X)
- Emi Sato (ORCID: https://orcid.org/0000-0003-2625-1548)
- Koichi Shiraishi
Institutions
- Tokai University (JP)
- University of Tokyo Health Sciences (JP)
Publication Details
- Journal
- Cancers
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3390/cancers16213610
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.37